The article explores eight companies that are leveraging allogeneic cell therapy for cancer treatments, including A2 Biotherapeutics, Adicet Bio, Caribou Biosciences, Coeptis Therapeutics, Cytovia Therapeutics, IN8Bio, Poseida Therapeutics, and TC BioPharm. The global allogeneic cell therapy market, valued at $255.6 million in 2022, is expected to reach $1.72 billion by 2030, driven by advancements in gene editing and an increasing number of clinical trials.
Boy, 17, among two more arrested on suspicion of murder after collision involving pedestrian
Two more people – including a 17-year-old boy – have been arrested on suspicion of murder after a man died following a collision in Barnsley.
